Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delong Liu

Showing results (11-20 of 287) with videos related to

Pageof 29
Sort By:
Biomarker Research|November 8, 2019
Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemiaBo Yu, Delong Liu
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|June 26, 2014
[Coblation-channelling for the tongue]Qingfeng Zhang, Delong Liu
Journal of Hematology & Oncology|June 6, 2020
Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myelomaBo Yu, Delong Liu
Journal of Hematology & Oncology|September 11, 2019
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myelomaBo Yu, Delong Liu
Experimental Hematology & Oncology|September 18, 2015
Novel antidotes for target specific oral anticoagulantsArundhati Das, Delong Liu
Stem Cell Investigation|August 9, 2016
Chimeric antigen receptor (CAR)-directed adoptive immunotherapy: a new era in targeted cancer therapyYamei Chen, Delong Liu
Journal of Hematology & Oncology|September 26, 2018
Cytokine release syndrome: grading, modeling, and new therapyDelong Liu, Juanjuan Zhao
Stem Cell Investigation|May 23, 2017
Bilateral obstructive renal calculi leading to severe kidney injurySrikanth Yandrapalli, Delong Liu
Biomarker Research|February 14, 2017
Diagnosis and treatment of CD20 negative B cell lymphomasTasleem Katchi, Delong Liu
Experimental Hematology & Oncology|August 21, 2019
Frontline therapies for untreated chronic lymphoid leukemiaDelong Liu, Juanjuan Zhao
Pageof 29

Showing results (11-20 of 287) with videos related to

Sort By:
Pageof 29
Biomarker Research|November 8, 2019
Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemiaBo Yu, Delong Liu
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|June 26, 2014
[Coblation-channelling for the tongue]Qingfeng Zhang, Delong Liu
Journal of Hematology & Oncology|June 6, 2020
Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myelomaBo Yu, Delong Liu
Journal of Hematology & Oncology|September 11, 2019
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myelomaBo Yu, Delong Liu
Experimental Hematology & Oncology|September 18, 2015
Novel antidotes for target specific oral anticoagulantsArundhati Das, Delong Liu
Stem Cell Investigation|August 9, 2016
Chimeric antigen receptor (CAR)-directed adoptive immunotherapy: a new era in targeted cancer therapyYamei Chen, Delong Liu
Journal of Hematology & Oncology|September 26, 2018
Cytokine release syndrome: grading, modeling, and new therapyDelong Liu, Juanjuan Zhao
Stem Cell Investigation|May 23, 2017
Bilateral obstructive renal calculi leading to severe kidney injurySrikanth Yandrapalli, Delong Liu
Biomarker Research|February 14, 2017
Diagnosis and treatment of CD20 negative B cell lymphomasTasleem Katchi, Delong Liu
Experimental Hematology & Oncology|August 21, 2019
Frontline therapies for untreated chronic lymphoid leukemiaDelong Liu, Juanjuan Zhao
Pageof 29